Inhalimed

Company Overview

Snapshot

Founded in July 2024, Inhalimed operates with 1–10 employees and is currently in the Pre-Funding stage. The company is focused on developing next-generation high-precision nebulizers, signaling its commitment to advancing drug delivery technologies within the health tech sector.

Business overview

Inhalimed is a Health Tech & Life Sciences company specializing in the development of next-generation high-precision nebulizers. Its core technology aims to enhance inhalation delivery for both pharmaceutical and wellness applications, serving the healthcare and life sciences markets, particularly within the pharmaceutical sector. The company operates within the Pharma & Medical Biotechnology and Drug Delivery categories.

Company Intelligence Q&A

What is Inhalimed's primary focus?

Inhalimed is focused on developing the next generation of high-precision nebulizers to improve inhalation delivery for pharmaceutical and wellness applications.

When was Inhalimed founded?

Inhalimed was founded in July 2024.

What sector does Inhalimed operate in?

Inhalimed operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drug Delivery.

What is Inhalimed's product stage?

Inhalimed's product is currently in the R&D stage.

Who is the CEO of Inhalimed?

Oron Zachar is the CEO of Inhalimed.